egtazic acid has been researched along with neuropeptide y in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bitran, M; Huidobro-Toro, JP; Torres, G | 1 |
| Carroll, BL; Crowley, WR; Dockter, ME; Kalra, SP; Kennedy, D; Shah, GV | 1 |
| Daniels, AJ; Lapetina, EG; Lazarowski, ER; Matthews, JE | 1 |
| Edvinsson, L; Ekblad, E; Håkanson, R; Wahlestedt, C | 1 |
| Aoki, Y; Kodama, H; Matsumoto, T; Nakamura, M; Noma, M; Ogasawara, H; Sakanaka, C; Shimizu, T; Tsuji, T | 1 |
| McCullough, LA; Westfall, TC | 1 |
| Lafond, J; Masse, A; Robidoux, J; Simoneau, L; St-Pierre, S | 1 |
| Dulcis, D; Spitzer, NC | 1 |
| Fu, LY; van den Pol, AN | 1 |
9 other study(ies) available for egtazic acid and neuropeptide y
| Article | Year |
|---|---|
Co-release of neuropeptide Y (NPY) and noradrenaline from the sympathetic nerve terminals supplying the rat vas deferens; influence of calcium and the stimulation intensity.
Topics: Animals; Calcium; Egtazic Acid; Electric Stimulation; Epididymis; In Vitro Techniques; Kinetics; Male; Nerve Fibers; Neuropeptide Y; Norepinephrine; Prostate; Rats; Rats, Sprague-Dawley; Sympathetic Nervous System; Time Factors; Tritium; Vas Deferens | 1992 |
Neuropeptide-Y enhances luteinizing hormone (LH)-releasing hormone-induced LH release and elevations in cytosolic Ca2+ in rat anterior pituitary cells: evidence for involvement of extracellular Ca2+ influx through voltage-sensitive channels.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channels; Cytosol; Egtazic Acid; Female; Gonadotropin-Releasing Hormone; Luteinizing Hormone; Neuropeptide Y; Nitrendipine; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains | 1990 |
Neuropeptide Y mobilizes intracellular Ca2+ and increases inositol phosphate production in human erythroleukemia cells.
Topics: Benzofurans; Calcium; Dose-Response Relationship, Drug; Egtazic Acid; Fluorescent Dyes; Fura-2; Humans; Inositol Phosphates; Kinetics; Leukemia, Erythroblastic, Acute; Neuropeptide Y; Spectrometry, Fluorescence; Tumor Cells, Cultured; Type C Phospholipases | 1989 |
Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action.
Topics: Animals; Drug Synergism; Egtazic Acid; Female; In Vitro Techniques; Male; Nerve Tissue Proteins; Neuropeptide Y; Nifedipine; Norepinephrine; Ouabain; Peptide YY; Peptides; Rabbits; Sodium; Vasoconstriction | 1985 |
Identification of two isoforms of mouse neuropeptide Y-Y1 receptor generated by alternative splicing. Isolation, genomic structure, and functional expression of the receptors.
Topics: Alternative Splicing; Amino Acid Sequence; Androstadienes; Animals; Base Sequence; Bone Marrow; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Cell Membrane; Chelating Agents; CHO Cells; Cricetinae; DNA Primers; DNA, Complementary; Egtazic Acid; Enzyme Inhibitors; Gene Expression; Gene Library; Humans; Introns; Kinetics; Mice; Molecular Sequence Data; Neuropeptide Y; Pertussis Toxin; Polymerase Chain Reaction; Protein Structure, Secondary; Receptors, Neuropeptide Y; Recombinant Proteins; Transfection; Virulence Factors, Bordetella; Wortmannin | 1995 |
Mechanism of catecholamine synthesis inhibition by neuropeptide Y: role of Ca2+ channels and protein kinases.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adenine; Animals; Calcium Channel Blockers; Calcium Channels; Calcium-Calmodulin-Dependent Protein Kinases; Carcinogens; Catecholamines; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Egtazic Acid; Enzyme Inhibitors; Imidazoles; Ion Channel Gating; Isoquinolines; Neuropeptide Y; Nifedipine; omega-Conotoxin GVIA; PC12 Cells; Peptides; Piperazines; Protein Kinase C; Protein Kinases; Protein Synthesis Inhibitors; Rats; Tetradecanoylphorbol Acetate; Thionucleotides | 1996 |
Characterization of neuropeptide Y-mediated corticotropin-releasing factor synthesis and release from human placental trophoblasts.
Topics: Arginine; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Chelating Agents; Corticotropin-Releasing Hormone; Egtazic Acid; Enzyme Activation; Female; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neuropeptide Y; Pertussis Toxin; Pregnancy; Receptors, Neuropeptide Y; Trophoblasts; Virulence Factors, Bordetella | 2000 |
Illumination controls differentiation of dopamine neurons regulating behaviour.
Topics: Animals; Behavior, Animal; Cell Count; Cell Differentiation; Chelating Agents; Dopamine; Egtazic Acid; Gene Expression Regulation, Developmental; Larva; Light; Lighting; Melanotrophs; Neurons; Neuropeptide Y; Photic Stimulation; Skin Pigmentation; Sodium Channel Blockers; Suprachiasmatic Nucleus; Tetrodotoxin; Xenopus laevis | 2008 |
Kisspeptin directly excites anorexigenic proopiomelanocortin neurons but inhibits orexigenic neuropeptide Y cells by an indirect synaptic mechanism.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Arcuate Nucleus of Hypothalamus; Axons; Calcium Channel Blockers; Chelating Agents; Dose-Response Relationship, Drug; Egtazic Acid; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Female; Gene Expression Regulation; Green Fluorescent Proteins; Imidazoles; In Vitro Techniques; Kisspeptins; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Neuropeptide Y; Patch-Clamp Techniques; Pro-Opiomelanocortin; Receptors, G-Protein-Coupled; Receptors, Kisspeptin-1; Renilla; RNA, Messenger; Sodium-Calcium Exchanger; Thiourea; Tumor Suppressor Proteins | 2010 |